Diabetes Drug Spend Could Rise 70 Percent By 2009, Medco Predicts
This article was originally published in The Pink Sheet Daily
Executive Summary
Driven by rising obesity rates, spending on diabetes therapies rose 14.5 percent from 2005 to 2006, firm’s annual Drug Trend Report states.
You may also be interested in...
Medco Will Buy PolyMedica In $1.5 Billion Deal
Acquisition expands Medco's presence in diabetes, where PolyMedica is best known for its Liberty brand of testing supplies.
Medco Will Buy PolyMedica In $1.5 Billion Deal
Acquisition expands Medco's presence in diabetes, where PolyMedica is best known for its Liberty brand of testing supplies.
Janumet Approved; Type 2 Diabetes Therapy Will Be Available By End Of April
Price for the Januvia/metformin combo will be the same as for Januvia alone, Merck tells “The Pink Sheet” DAILY.